Markers of liver injury and clinical outcomes in COVID-19 patients: A systematic review and meta-analysis
- PMID: 32474033
- PMCID: PMC7255758
- DOI: 10.1016/j.jinf.2020.05.045
Markers of liver injury and clinical outcomes in COVID-19 patients: A systematic review and meta-analysis
Conflict of interest statement
Declaration of Competing Interest None.
Figures


Comment in
-
Aspartate aminotransferase: A prognostic marker rather than a specific liver injury marker in COVID-19.J Infect. 2020 Aug;81(2):e155. doi: 10.1016/j.jinf.2020.06.007. Epub 2020 Jun 7. J Infect. 2020. PMID: 32525000 Free PMC article. No abstract available.
-
Clinically significant portal hypertension in cirrhosis patients with COVID-19: Clinical characteristics and outcomes.J Infect. 2020 Aug;81(2):e178-e180. doi: 10.1016/j.jinf.2020.06.029. Epub 2020 Jun 17. J Infect. 2020. PMID: 32562796 Free PMC article. No abstract available.
-
Serum cholinesterase associated with COVID-19 pneumonia severity and mortality.J Infect. 2021 Feb;82(2):282-327. doi: 10.1016/j.jinf.2020.08.021. Epub 2020 Aug 19. J Infect. 2021. PMID: 32822684 Free PMC article. No abstract available.
Comment on
-
Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study.Lancet. 2020 Mar 28;395(10229):1054-1062. doi: 10.1016/S0140-6736(20)30566-3. Epub 2020 Mar 11. Lancet. 2020. PMID: 32171076 Free PMC article.
References
-
- Kunutsor SK, Apekey TA, Laukkanen JA. Association of serum total osteocalcin with type 2 diabetes and intermediate metabolic phenotypes: systematic review and meta-analysis of observational evidence. Eur J Epidemiol. 2015;30(8):599–614. AugPubMed PMID: 26085114. Epub 2015/06/19. - PubMed
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical